EBR Systems (EBRCZ) Gross Margin (2025 - 2026)
EBR Systems' (EBRCZ) quarterly Gross Margin came in at 7.79% in Q1 2026, down 59.94% quarter-over-quarter from 19.44% in Q4 2025.
Analysis
EBR Systems (EBRCZ) Gross Margin (2025 - 2026) Analysis & Trends
EBR Systems has disclosed Gross Margin across 2 years of filings, most recently posting 7.79% for Q1 2026.
- In Q1 2026, Gross Margin changed N/A year-over-year to 7.79%; the TTM figure through Mar 2026 stood at 16.94% (changed N/A YoY), while the FY2025 annual figure was 30.3%, changed N/A from the prior year.
- Gross Margin came in at 7.79% for Q1 2026 at EBR Systems, down from 19.44% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 49.75% in Q2 2025 to a low of 7.79% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 45.84% |
| 10 | EBR Systems | 10.83 Mn | 10.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 7.79% |
| Dec 31, 2025 | 19.44% |
| Sep 30, 2025 | 43.69% |
| Jun 30, 2025 | 49.75% |